Kubota Pharmaceutical Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KBBTF research report →
Price Chart
About the company
Kubota Pharmaceutical Holdings Co. , Ltd. operates globally, concentrating on the development of innovative drugs and medical devices within the ophthalmology sector.
- CEO
- Ryo Kubota
- IPO
- 2017
- Employees
- 7
- HQ
- Tokyo, JP
Get TickerSpark's AI analysis on KBBTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $24.10M
- P/E
- -8.33
- PEG
- -0.08
- P/S
- 586.76
- P/B
- 6.29
- EV/EBITDA
- -7.39
- Div Yield
- 0.00%
- Gross Margin
- -157.34%
- Op Margin
- -6634.39%
- Net Margin
- -5389.13%
- ROE
- -51.34%
- ROIC
- -66.63%
- 52W High
- $2.81
- 52W Low
- $0.96
- 50D MA
- $2.74
- 200D MA
- $2.79
- Beta
- 1.18
- RSI (14)
- 12
- Avg Volume
- 3
No earnings-call transcripts are available for KBBTF yet.
- Free Float
- 169.6%
- Shares Outstanding
- 25.10M
- Float Shares
- 42.57M
Our KBBTF coverage
Recent articles, reports, and earnings notes.
No research on KBBTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KBBTF report →